Singapore markets close in 3 hours 24 minutes
Straits Times Index
3,298.23 +5.54 (+0.17%) Nikkei
38,285.24 +11.19 (+0.03%) Hang Seng
18,174.80 +411.77 (+2.32%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,204.30 -2,770.29 (-4.62%) CMC Crypto 200
1,260.07 -79.00 (-5.90%)
ABT Jan 2025 100.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:14PM EDT. Market open.
| Previous close | 13.47 |
| Open | 13.50 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 100.00 |
| Expiry date | 2025-01-17 |
| Day's range | 13.47 - 13.50 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.